These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 875120)

  • 1. [Our experience in palliative treatment of certain prostatic cancers by high-dosage estrogens combined with corticotherapy].
    Neveu J; Soton G; Roche G; Cisterne JP
    J Urol Nephrol (Paris); 1977; 83(1-2):143-5. PubMed ID: 875120
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endocrinologic therapy of prostatic cancer].
    Nihira H
    Nihon Hinyokika Gakkai Zasshi; 1986 Dec; 77(12):1910-4. PubMed ID: 3586440
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocrine factors in the treatment of prostatic cancer.
    Pierrepoint CG; Turkes AO; Walker KJ; Harper ME; Wilson DW; Peeling WB; Griffiths K
    Prog Clin Biol Res; 1985; 185A():51-72. PubMed ID: 3162177
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a combination antiemetic regimen including iv high-dose metoclopramide, dexamethasone, and diphenhydramine in cisplatin-based chemotherapy regimens.
    Rosell R; Abad-Esteve A; Ribas-Mundo M; Moreno I
    Cancer Treat Rep; 1985; 69(7-8):909-10. PubMed ID: 4040428
    [No Abstract]   [Full Text] [Related]  

  • 5. [Randomized controlled study of high-dose metoclopramide and dexamethasone in the prevention of CDDP-induced emesis].
    Umehara H; Sawamura N; Takahashi S; Kusano H; Yokoyama S; Suemasu K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1996-8. PubMed ID: 3010886
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hormonal therapy of prostatic carcinoma].
    Martz G
    Internist (Berl); 1968 Sep; 9(9):375-80. PubMed ID: 4918657
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
    Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Mae M; Fukuda M; Ohe Y; Sasaki S
    Jpn J Clin Oncol; 1989 Mar; 19(1):40-4. PubMed ID: 2921817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormonotherapy of so-called solid tumors].
    Cappelaere P
    Sem Hop; 1972 Jan; 48(4):279-82. PubMed ID: 4338349
    [No Abstract]   [Full Text] [Related]  

  • 10. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience of hormone therapy to bone metastatic prostate cancer.
    Wakisaka M; Nomura K
    Int J Urol; 2006 May; 13(5):550-4. PubMed ID: 16771724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
    Honda M; Takasaki E; Suzuki T; Maeda S; Imai T; Hosoya Y; Chen JA
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of prostate cancer with a large abdominal mass effectively treated with a high dose of diethylstilbestrol-diphosphate.
    Wakisaka M; Takagishi H
    Hinyokika Kiyo; 1993 Sep; 39(9):849-51. PubMed ID: 8213382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of hormonal and cytostatic treatment for advanced carcinoma of the prostate.
    Servadio C
    Prog Clin Biol Res; 1985; 185A():407-26. PubMed ID: 4034582
    [No Abstract]   [Full Text] [Related]  

  • 15. Ondansetron against metoclopramide/dexamethasone--a comparative study.
    Lim AK; Haron MR; Yap TM
    Med J Malaysia; 1994 Sep; 49(3):231-8. PubMed ID: 7845271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diethylstilbestrol di-trimethylacetate (DSTMA). A long-acting estrogen.
    Noland JL; Amin M
    Invest Urol; 1980 May; 17(6):506-9. PubMed ID: 7372439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intravenous stilbestrol diphosphate in patients with prostatic carcinoma refractory to conventional hormonal manipulation.
    Ferro MA
    Urol Clin North Am; 1991 Feb; 18(1):139-43. PubMed ID: 1992567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of dexamethasone and metoclopramide as antiemetics in children receiving cancer chemotherapy.
    Basade M; Kulkarni SS; Dhar AK; Sastry PS; Saikia B; Advani SH
    Indian Pediatr; 1996 Apr; 33(4):321-3. PubMed ID: 8772908
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormone and adjuvant therapy in advanced cancers].
    Bonard EC
    Praxis; 1966 Jun; 55(24):676-9. PubMed ID: 6014097
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer].
    Ushiyama T; Ihara H; Kurita Y; Kageyama S; Ueda D; Mugiya S; Yamaguchi Y; Nakano M; Suzuki K; Kawabe K
    Hinyokika Kiyo; 1993 Dec; 39(12):1139-44. PubMed ID: 8285162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.